The urinary System

The urinary system, also known as the renal system, is responsible for  filtering blood to remove waste products, regulating electrolyte  balance, controlling blood pressure, and maintaining fluid balance  within the body. It consists of several organs, including the kidneys,  ureters, bladder, and urethra. The kidneys are the primary organs of the  urinary system and perform essential functions such as filtering waste  products and excess substances from the blood to form urine, regulating  blood volume and pressure by adjusting water and electrolyte balance,  and producing hormones like renin and erythropoietin. Urine produced by  the kidneys travels through the ureters to the bladder, where it is  stored until it is expelled from the body through the urethra during  urination. Overall, the urinary system plays a crucial role in  maintaining internal homeostasis by eliminating metabolic waste  products, regulating fluid and electrolyte balance, and supporting other  physiological processes. 

 Acute Kidney Injury (AKI): 

AKI, formerly known as acute renal failure, is a sudden and often reversible loss of kidney function. It can occur due to various factors such as dehydration, severe infection, kidney obstruction, or exposure to nephrotoxic drugs. Symptoms include decreased urine output, fluid retention, electrolyte imbalances, and fatigue

Chronic Kidney Disease (CKD): 

CKD is a progressive condition characterized by the gradual loss of kidney function over time. It can result from various underlying health issues such as diabetes, high blood pressure, and glomerulonephritis. Symptoms may not be apparent in the early stages, but as the disease progresses, individuals may experience fatigue, swelling in the extremities, changes in urination patterns, and complications like anemia and bone disease.

.

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): 

IC/BPS is a chronic condition characterized by bladder pain, urinary urgency, frequency, and nocturia (frequent urination during the night). The exact cause of IC/BPS is not well understood, but it may involve abnormalities in the bladder lining, nerve dysfunction, or immune system dysfunction.

Kidney Stones (Renal Calculi): 

Kidney stones are hard mineral and salt deposits that form within the kidneys. They can vary in size and may cause intense pain as they pass through the urinary tract. Common symptoms include severe flank or abdominal pain, blood in the urine, and difficulty urinating.

Polycystic Kidney Disease (PKD): 

PKD is a genetic disorder characterized by the growth of numerous fluid-filled cysts in the kidneys. These cysts can interfere with kidney function over time, leading to complications such as high blood pressure, kidney stones, urinary tract infections, and kidney failure.

These are some of the major disorders affecting the urinary system, each with its own set of causes, symptoms, and treatment approaches. Prompt medical attention is essential for proper diagnosis and management of these conditions.

Urinary Incontinence: 

Urinary incontinence is the involuntary leakage of urine, which can significantly impact an individual's quality of life. It can result from various factors such as weak pelvic floor muscles, nerve damage, hormonal changes, or underlying medical conditions. Types of urinary incontinence include stress incontinence, urge incontinence, overflow incontinence, and functional incontinence.

Urinary Retention: 

Urinary retention is the inability to empty the bladder fully. It can be acute or chronic and may result from various factors such as bladder outlet obstruction (e.g., enlarged prostate, urinary tract stones), nerve dysfunction, medications, or weak bladder muscles.

Albuminuria and Proteinuria: 

Hyperinsulinemia, insulin resistance, and metabolic syndrome are associated with an increased risk of albuminuria and proteinuria, which are indicators of kidney damage and dysfunction. Insulin resistance can impair the filtration and reabsorption functions of the kidneys, leading to increased urinary excretion of albumin and proteins. Additionally, metabolic syndrome-related conditions such as hypertension and dyslipidemia can further contribute to kidney damage and the development of albuminuria and proteinuria.

Chronic Kidney Disease (CKD): 

Insulin resistance and metabolic syndrome are associated with an increased risk of developing chronic kidney disease (CKD). The chronic inflammatory state and oxidative stress associated with insulin resistance can contribute to the progression of kidney damage over time. Moreover, metabolic syndrome components such as hypertension and dyslipidemia can further exacerbate kidney injury, leading to the development or worsening of CKD.

Kidney Function: 

Hyperinsulinemia, insulin resistance, and metabolic syndrome can contribute to kidney dysfunction through various mechanisms. Insulin resistance may lead to impaired insulin signaling in the kidneys, resulting in decreased glucose uptake and utilization, which can contribute to glomerular dysfunction and renal damage. Additionally, metabolic syndrome components such as hypertension and dyslipidemia can exacerbate kidney injury by promoting inflammation, oxidative stress, and endothelial dysfunction.

Kidney Stones: 

Insulin resistance and metabolic syndrome components such as obesity and dyslipidemia are associated with an increased risk of kidney stone formation. Insulin resistance may promote urinary calcium excretion and reduce citrate levels, increasing the likelihood of calcium oxalate stone formation. Obesity, a common feature of metabolic syndrome, is also associated with alterations in urine composition and volume, which can predispose individuals to kidney stone formation.

Urinary Tract Infections (UTIs): 

Insulin resistance and metabolic syndrome are associated with an increased risk of urinary tract infections (UTIs). Insulin resistance can impair immune function and increase susceptibility to infections, including UTIs. Additionally, metabolic syndrome-related conditions such as obesity and diabetes can create a favorable environment for bacterial growth in the urinary tract, leading to an increased risk of UTIs.

 Puts strain on the kidneys, increasing the risk of kidney stones and urinary incontinence. 

 Can lead to diabetic nephropathy, kidney failure, and urinary tract infections due to high blood sugar levels and hypertension. 

  Frequent urination can be caused by various factors including urinary  tract infections, diabetes, overactive bladder, enlarged prostate (in  men), interstitial cystitis, pregnancy, neurological conditions, bladder  stones, certain medications, and consumption of diuretics like caffeine  and alcohol.

 Hyperinsulinemia, which is characterized by high levels of insulin in  the blood, can affect urination frequency through its association with  diabetes. When insulin levels are consistently elevated, as in cases of  insulin resistance or type 2 diabetes, it can lead to increased glucose  levels in the blood. The kidneys attempt to remove excess glucose by  filtering it into the urine, resulting in more frequent urination, a  condition known as polyuria. Therefore, hyperinsulinemia, particularly  in the context of insulin resistance or diabetes, can contribute to  frequent urination due to its impact on blood glucose levels. 

  Urinary incontinence is the involuntary leakage of urine, which can significantly impact an individual's quality of life. It can result from various factors such as weak pelvic floor muscles, nerve damage, hormonal changes, or underlying medical conditions. Types of urinary incontinence include stress incontinence, urge incontinence, overflow incontinence, and functional incontinence.

While the direct impact of insulin resistance and metabolic syndrome on urinary incontinence is not well-established, obesity, a common feature of metabolic syndrome, is a significant risk factor for urinary incontinence. Obesity-related factors such as increased intra-abdominal pressure and mechanical stress on the pelvic floor muscles can contribute to urinary incontinence.

Abstract 

Introduction and hypothesis: The objective was to identify the associations between metabolic syndrome (MS) and stress urinary incontinence (SUI) in women and to provide an evidence base for clinical practice. 

Methods: A meta-analysis of cohort, case-control, and cross-sectional studies about the association between MS and SUI was performed using databases including PubMed, Cochrane Library, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), China Biology Medicine disc (CBMdisc), Wanfang Database (WanFang Data), and VIP database (VIP). The time limit was from the commencement of each database to 1 November 2020. Two researchers independently screened literature, extracted data, and assessed the risk of bias. RevMan 5.3 software was used for statistical analysis. The dichotomous variables were presented as the risk ratio (odds ratio, OR) and 95% CI as the effect indicators. 

Results: Six studies were included in the meta-analysis, with a total sample size of 3,678 cases. The results showed that the risk for SUI in women with MS was three times those without MS (OR = 3.41, 95% CI 2.01, 5.77, p <0.00001), and the difference was statistically significant. The results of subgroup analysis showed that MS was significantly associated with SUI in the subgroups of pre- and postmenopausal women (OR = 2.46, 95% CI 1.63, 3.73, p < 0.00001), and in the subgroups of other types of women (OR = 3.41, 95% CI 2.01, 5.77, p = 0.0003), and the differences were statistically significant. 

Conclusions: Metabolic syndrome is associated with SUI in women and increases its risk. 

 
 Urinary retention is the inability to empty the bladder fully. It can be acute or chronic and may result from various factors such as bladder outlet obstruction (e.g., enlarged prostate, urinary tract stones), nerve dysfunction, medications, or weak bladder muscles.

While the direct impact of hyperinsulinemia, insulin resistance, and metabolic syndrome on urinary retention is not well-established, conditions such as diabetes, often associated with insulin resistance, can lead to nerve damage and dysfunction, including neuropathy affecting bladder function.

 
Hyperuricemia" is a medical condition characterized by elevated levels  of uric acid in the blood. It can lead to the formation of crystals in  the joints, causing gout, or contribute to the development of kidney  stones or kidney disease. 

Kidney stones are hard mineral and salt deposits that form within the kidneys. They can vary in size and may cause intense pain as they pass through the urinary tract. Common symptoms include severe flank or abdominal pain, blood in the urine, and difficulty urinating.. Insulin resistance may promote urinary calcium excretion and reduce citrate levels, increasing the likelihood of calcium oxalate stone formation.

Kidney disease, also known as renal disease, refers to a condition in which the kidneys become damaged and cannot perform their functions effectively. The kidneys are vital organs responsible for filtering waste products and excess fluids from the blood, regulating electrolyte balance, and producing hormones that regulate blood pressure and red blood cell production.

Kidney disease can range from mild to severe and may be acute or chronic. Acute kidney disease occurs suddenly and is often caused by conditions such as dehydration, infection, or trauma. Chronic kidney disease CKD  develops over time and is usually caused by conditions such as diabetes, high blood pressure, or autoimmune diseases.

Common symptoms of kidney disease include fatigue, swelling in the legs, ankles, or feet, changes in urination frequency or color, difficulty sleeping, and decreased appetite. However, in the early stages, kidney disease may not cause any symptoms and can only be detected through blood tests or urine tests.

 Polycystic Kidney Disease (PKD  is a genetic disorder characterized by the  growth of numerous cysts in the kidneys. It is caused by genetic  mutations, typically inherited from one or both parent.  

 PKD is characterized by the growth of fluid-filled cysts in the kidneys,  which can gradually increase in size and number over time. These cysts  can interfere with kidney function by replacing normal kidney tissue,  leading to complications such as high blood pressure, kidney stones, and  kidney failure  Common sytems include abdominal pain, blood in the urine, frequent urinary tract infections, kidney stones, and high blood pressure. 

In the the early stages, both CKD and PKD can be asymptomatic 

Treatment for kidney disease depends on the underlying cause and severity of the condition. In some cases, lifestyle changes such as diet modifications, exercise, and quitting smoking may help slow the progression of the disease. Medications may also be prescribed to control blood pressure, manage blood sugar levels, or treat underlying conditions. In advanced cases, kidney transplant or dialysis may be necessary to replace the lost kidney function. Early detection and treatment are crucial for managing kidney disease and preventing complications. Regular monitoring and follow-up with a healthcare provider are essential for individuals with kidney disease.

1. Oyabu  C, Hashimoto Y, Fukuda T, et al. Impact of low-carbohydrate diet on  renal function: a meta-analysis of over 1000 individuals from nine  randomised controlled trials. Br J Nutr. 2016;116(4):632-638. doi:10.1017/S0007114516002178 
2. Suyoto  PST. Effect of low-carbohydrate diet on markers of renal function in  patients with type 2 diabetes: A meta-analysis. Diabetes Metab Res Rev.  2018;34(7):e3032. doi:10.1002/dmrr.3032 ABSTRACT
3. Devries  MC, Sithamparapillai A, Brimble KS, Banfield L, Morton RW, Phillips SM.  Changes in Kidney Function Do Not Differ between Healthy Adults  Consuming Higher- Compared with Lower- or Normal-Protein Diets: A  Systematic Review and Meta-Analysis. The Journal of Nutrition. 2018;148(11):1760-1775. doi:10.1093/jn/nxy197
4. Weimbs, T., Saville, J. and Kalantar-Zadeh, K. (2023) ‘Ketogenic metabolic therapy for chronic kidney disease – the pro part’, Clinical Kidney Journal, p. sfad273. Available at: https://doi.org/10.1093/ckj/sfad273. See Joshi et al. (2023) for: Risks of the ketogenic diet in CKD – the con part

1. Cukoski, S. et al. (2023) ‘Feasibility and impact of ketogenic dietary interventions in  polycystic kidney disease: KETO-ADPKD—a randomized controlled trial’, Cell Reports Medicine, 0(0). Available at: https://doi.org/10.1016/j.xcrm.2023.101283.
2. A,  Golan R, Harman-Boehm I, et al. Renal function following three distinct  weight loss dietary strategies during 2 years of a randomized  controlled trial. Diabetes Care. 2013;36(8):2225-2232. doi:10.2337/dc12-1846 
3. Zainordin  NA, Warman NAE, Mohamad AF, et al. Safety and efficacy of very low  carbohydrate diet in patients with diabetic kidney disease—A randomized  controlled trial. PLOS ONE. 2021;16(10):e0258507. doi:10.1371/journal.pone.0258507
4. Unwin  D, Unwin J, Crocombe D, Delon C, Guess N, Wong C. Renal function in  patients following a low carbohydrate diet for type 2 diabetes: a review  of the literature and analysis of routine clinical data from a primary  care service over 7 years. Current Opinion in Endocrinology, Diabetes and Obesity. Published online July 23, 2021. doi:10.1097/MED.0000000000000658
5. ATHINARAYANAN, S.J. et al. (2023) ‘410-P: Two-Year (2y) eGFR Slope in People with Type 2 Diabetes  (T2D) Receiving a Very Low Carbohydrate Diet (VLCD) Intervention’, Diabetes, 72(Supplement_1), pp. 410-P. Available at: https://doi.org/10.2337/db23-410-P.
6. Bruci  A, Tuccinardi D, Tozzi R, et al. Very Low-Calorie Ketogenic Diet: A  Safe and Effective Tool for Weight Loss in Patients With Obesity and  Mild Kidney Failure. Nutrients. 2020;12(2):333. doi:10.3390/nu12020333
7. Mitchell  NS, Batch BC, Tyson CC. Retrospective cohort study of changes in  estimated glomerular filtration rate for patients prescribed a low carb  diet. Curr Opin Endocrinol Diabetes Obes. Published online August 12, 2021. doi:10.1097/MED.0000000000000673
8. Nielsen  JV, Westerlund P, Bygren P. A low-carbohydrate diet may prevent  end-stage renal failure in type 2 diabetes. A case report. Nutrition  & Metabolism. 2006;3(1):23. doi:10.1186/1743-7075-3-23
9. Friedman  AN, Ogden LG, Foster GD, et al. Comparative effects of low-carbohydrate  high-protein versus low-fat diets on the kidney. Clin J Am Soc Nephrol.  2012;7(7):1103-1111. doi:10.2215/CJN.11741111 
10. Brinkworth  GD, Buckley JD, Noakes M, Clifton PM. Renal Function Following  Long-Term Weight Loss in Individuals with Abdominal Obesity on a  Very-Low-Carbohydrate Diet vs High-Carbohydrate Diet. Journal of the  American Dietetic Association. 2010;110(4):633-638. doi:10.1016/j.jada.2009.12.016 ABSTRACT 
11. Tay  J, Thompson CH, Luscombe-Marsh ND, et al. Long-Term Effects of a Very  Low Carbohydrate Compared With a High Carbohydrate Diet on Renal  Function in Individuals With Type 2 Diabetes: A Randomized Trial.  Medicine (Baltimore). 2015;94(47):e2181. doi:10.1097/MD.0000000000002181 ABSTRACT
12. Truche, A.-S. et al. (2022) ‘A Specific High-Protein Weight Loss Program Does Not Impair Renal Function in Patients Who Are Overweight/Obese’, Nutrients, 14(2), p. 384. doi:10.3390/nu14020384.
13. ROBERTS, C.G.P. et al. (2022) ‘212-OR: Five-Year Follow-Up of Lipid, Inflammatory, Hepatic,  and Renal Markers in People with T2 Diabetes on a Very-Low-Carbohydrate  Intervention Including Nutritional Ketosis (VLCI) via Continuous Remote  Care (CRC)’, Diabetes, 71(Supplement_1), pp. 212-OR. Available at: https://doi.org/10.2337/db22-212-OR.
14. Oehm, S. et al. (2022) ‘RESET-PKD: A pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease’, Nephrology,  Dialysis, Transplantation: Official Publication of the European  Dialysis and Transplant Association – European Renal Association, p. gfac311. Available at: https://doi.org/10.1093/ndt/gfac311.
15. Rojas-Morales, P. et al. (2021) ‘A ketogenic diet attenuates acute and chronic ischemic kidney  injury and reduces markers of oxidative stress and inflammation’, Life Sciences, p. 120227. doi:10.1016/j.lfs.2021.120227. (Preclinical)

1. Diet  Doctor Podcast with Dr Bret Scher, Dr Thomas Weimbs and registered  dietitian and renal nutrition expert Jessianna Saville – #102 – Keto  diets and kidney health (2022), Google Podcasts.
2. Diet Doctor Podcast with Dr Bret Scher and Dr Keith Runyan – #103 – Keto, type 1 diabetes, and kidneys (2022). Google Podcasts.

 Ketogenic diets have been widely used for weight loss and are  increasingly used in the management of type 2 diabetes. Despite evidence  that ketones have multiple positive effects on kidney function, common  misconceptions about ketogenic diets, such as high protein content and  acid load, have prevented their widespread use in individuals with  impaired kidney function. Clinical trial evidence focusing on major  adverse kidney events is sparse. The aim of this review is to explore  the effects of a ketogenic diet, with an emphasis on the pleiotropic  actions of ketones, on kidney health. Given the minimal concerns in  relation to the potential renoprotective effects of a ketogenic diet,  future studies should evaluate the safety and efficacy of ketogenic  interventions in kidney disease. 

Hyperuricemia" is a medical condition characterized by elevated levels  of uric acid in the blood. It can lead to the formation of crystals in  the joints, causing gout, or contribute to the development of kidney  stones or kidney disease.